86% of Americans surveyed say biggest GenAI in healthcare concern is lack of transparency on origin and vetting of information used.
A new Wolters Kluwer Health survey, Generative AI in Healthcare: Gaining Consumer Trust, reveals one of the biggest concerns Americans have about generative AI (GenAI) in healthcare is not knowing where the medical information being used came from or how it is validated.¹
For American health consumers, it’s all about the content
With GenAI making headlines throughout 2023, Americans are growing familiar with the technology and see its potential to improve healthcare. However almost nine out of ten Americans (86%) agree a problem with using GenAI in healthcare is not knowing where the information came from and/or how it was validated, while 82% agree another problem is that information may be coming from internet searches with no filter. Half of Americans (49%) say they are concerned GenAI might produce false information.
With certain criteria met, Americans’ concerns about GenAI being used in their healthcare start to dissipate. When asked if they would be concerned knowing that their healthcare provider was using GenAI, four out of five (80%) respondents said they would be concerned. However, that concern drops to three out of five (63%) if they knew their doctor was using GenAI that came from an established source in healthcare; that it was created by doctors and clinicians; and it was constantly being updated.